These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 37100941)

  • 21. Computational Approaches Towards Kinases as Attractive Targets for Anticancer Drug Discovery and Development.
    Hameed R; Khan A; Khan S; Perveen S
    Anticancer Agents Med Chem; 2019; 19(5):592-598. PubMed ID: 30306880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure based virtual screening to discover putative drug candidates: necessary considerations and successful case studies.
    Danishuddin M; Khan AU
    Methods; 2015 Jan; 71():135-45. PubMed ID: 25448480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SABRE: ligand/structure-based virtual screening approach using consensus molecular-shape pattern recognition.
    Wei NN; Hamza A
    J Chem Inf Model; 2014 Jan; 54(1):338-46. PubMed ID: 24328054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deep Learning in Virtual Screening: Recent Applications and Developments.
    Kimber TB; Chen Y; Volkamer A
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligand discovery and virtual screening using the program LIDAEUS.
    Taylor P; Blackburn E; Sheng YG; Harding S; Hsin KY; Kan D; Shave S; Walkinshaw MD
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S55-67. PubMed ID: 18037921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases.
    Rifaioglu AS; Atas H; Martin MJ; Cetin-Atalay R; Atalay V; Doğan T
    Brief Bioinform; 2019 Sep; 20(5):1878-1912. PubMed ID: 30084866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stalis: A Computational Method for Template-Based Ab Initio Ligand Design.
    Lee HS; Im W
    J Comput Chem; 2019 Jun; 40(17):1622-1632. PubMed ID: 30829435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insights into Machine Learning-based Approaches for Virtual Screening in Drug Discovery: Existing Strategies and Streamlining Through FP-CADD.
    Hussain W; Rasool N; Khan YD
    Curr Drug Discov Technol; 2021; 18(4):463-472. PubMed ID: 32767944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in the discovery of new chemotypes through ultra-large library docking.
    Potlitz F; Link A; Schulig L
    Expert Opin Drug Discov; 2023 Mar; 18(3):303-313. PubMed ID: 36714919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-Based Drug Discovery Accelerated by Many-Core Devices.
    Feinstein W; Brylinski M
    Curr Drug Targets; 2016; 17(14):1595-1609. PubMed ID: 26758669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virtual screening in small molecule discovery for epigenetic targets.
    Li GB; Yang LL; Yuan Y; Zou J; Cao Y; Yang SY; Xiang R; Xiang M
    Methods; 2015 Jan; 71():158-66. PubMed ID: 25462557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combating Diseases with Computational Strategies Used for Drug Design and Discovery.
    Makhouri FR; Ghasemi JB
    Curr Top Med Chem; 2018; 18(32):2743-2773. PubMed ID: 30663568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virtual Screening Approaches towards the Discovery of Toll-Like Receptor Modulators.
    Pérez-Regidor L; Zarioh M; Ortega L; Martín-Santamaría S
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An open-source drug discovery platform enables ultra-large virtual screens.
    Gorgulla C; Boeszoermenyi A; Wang ZF; Fischer PD; Coote PW; Padmanabha Das KM; Malets YS; Radchenko DS; Moroz YS; Scott DA; Fackeldey K; Hoffmann M; Iavniuk I; Wagner G; Arthanari H
    Nature; 2020 Apr; 580(7805):663-668. PubMed ID: 32152607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptor-based virtual screening protocol for drug discovery.
    Cerqueira NM; Gesto D; Oliveira EF; Santos-Martins D; Brás NF; Sousa SF; Fernandes PA; Ramos MJ
    Arch Biochem Biophys; 2015 Sep; 582():56-67. PubMed ID: 26045247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-dimensional compound comparison methods and their application in drug discovery.
    Shin WH; Zhu X; Bures MG; Kihara D
    Molecules; 2015 Jul; 20(7):12841-62. PubMed ID: 26193243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methods for generating and applying pharmacophore models as virtual screening filters and for bioactivity profiling.
    Vuorinen A; Schuster D
    Methods; 2015 Jan; 71():113-34. PubMed ID: 25461773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization methods for virtual screening on novel computational architectures.
    Pérez-Sánchez H; Wenzel W
    Curr Comput Aided Drug Des; 2011 Mar; 7(1):44-52. PubMed ID: 20883205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of computer-aided drug design in modern drug discovery.
    Macalino SJ; Gosu V; Hong S; Choi S
    Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.